发明名称 ASPIRIN-CONTAINING PHARMACEUTICAL AGENT
摘要 <p>Disclosed is a pharmaceutical agent effective for the prevention and/or treatment of a disease associated with the formation of a thrombus or embolus or a disease induced by the formation of a thrombus or embolus. The pharmaceutical agent comprises a combination of aspirin and any one of the following compounds (a) to (d): (a) a compound capable of acting on a calcium handling protein to modulate the intracellular calcium level or the rate of change in intracellular calcium level; (b) a compound capable of inhibiting the over-accumulation of a calcium ion in a cell; (c) a compound capable of inhibiting the over-accumulation of a sodium ion in a cell; and (d) an aminobenzenesulfonic acid derivative represented by the general formula (I), a salt thereof, or a hydrate or solvate of the derivative or the salt. (I) wherein R&lt;SUB&gt;1&lt;/SUB&gt; represents a C&lt;SUB&gt;1&lt;/SUB&gt;-C&lt;SUB&gt;6&lt;/SUB&gt; alkyl group or the like; R&lt;SUB&gt;2&lt;/SUB&gt; represents a hydrogen atom or the like; and n represents an integer of 1 to 4.</p>
申请公布号 WO2008032814(A1) 申请公布日期 2008.03.20
申请号 WO2007JP67910 申请日期 2007.09.14
申请人 MITSUBISHI TANABE PHARMA CORPORATION;WATANABE, MAYUMI 发明人 WATANABE, MAYUMI
分类号 A61K31/616;A61K31/495;A61K45/00;A61P7/02;A61P9/04;A61P9/08;A61P9/10;A61P41/00;A61P43/00;C07D295/08 主分类号 A61K31/616
代理机构 代理人
主权项
地址